Barry Arkles, Ph.D.

Dr. Barry Arkles is a universally recognized chemist who holds a PhD in Biochemistry from Temple University in Philadelphia, PA. Dr. Arkles has a record of accomplishment in materials science, chemistry, and biotechnology as an innovator and entrepreneur, as noted in contributions to many industrial applications including thermoplastic composites, the NASA space Shuttle, contact Lenses, dielectrics and metals for integrated circuitry (IC), and gene chips for DNA array analysis. Today the companies that he founded or co-founded generate nearly $1 billion in annual revenue and include:

  • President and Founder, Catemer, Inc., Doylestown, PA. Catemer is devoted to the development of macromolecular materials, both polymeric and macrocyclic, ranging from applications in therapeutics to additive manufacturing (3D printing) for biocompatible devices.
  • President and Founder, Gelest, Inc., Morrisville, PA. Dr. Arkles formed Gelest Inc., to develop and manufacture silicon and metal-organic based chemicals and polymers for applications in microelectronics, optoelectronics, diagnostics (including DNA array devices), medical devices and pharmaceuticals. Gelest Inc. was acquired by Mitsubishi Chemical Corporation in 2020 after reaching 500 annual jobs and over $125M in revenues per year.
  • Vice President, Corporate Development, Dynamit-Nobel America/Evonik, Piscataway, NJ. Dr. Arkles was responsible for all R&D and commercialization technology for Huls America. Huls, a $6 billion chemical manufacturer products ranging from colorants for consumer paints to advanced silicon technology, has since merged with Dynamit-Nobel to form Evonik.
  • President and Founder, Petrarch Systems, Bensalem and Bristol, PA. Dr. Arkles was involved in development and manufacture of advanced silicon and silicone products for medical devices, microelectronics and commercialization of advanced thermoplastic and fluoropolymer composites. These materials are employed in aerospace, medical applications, photographic and sports equipment. Petrarch Systems was acquired by Dynamit-Nobel in 1985 after reaching 200 annual jobs and $25M in revenue per year in 1980s dollars.

Dr. Arkes has published over 300 technical articles and primary patents relevant to a range of scientific fields including the semiconductor industry. Dr. Arkles was elected as member of the National Academy of Engineering in 2021 for contributions to organosilicon materials and organometallic and biochemical reagents. He is also a fellow of the Royal Chemical Society since 2013 and serves as Distinguished Professor of Chemistry-Temple University since 2021.


Alain E. Kaloyeros, Ph.D.

Dr. Alain E. Kaloyeros is a renowned physicist and economic development expert who over his career has generated the largest research and development (R&D) funding volume of any professor at any university in the U.S. with over $40 Billion in public and private funding, including two of the largest Federal grants ever awarded to a university: the Department of Energy U.S. Photovoltaic Manufacturing Consortium ($62.5M) and the Department of Defense National Network for Manufacturing Innovation in Photonics ($110M). Dr. Kaloyeros led the development and implementation of New York’s high-tech strategy to become a global leader in the nanotechnology driven economy of the 21st Century. A critical cornerstone of New York’s high technology strategy was the establishment of SUNY Polytechnic Institute (SUNY Poly) as a truly global resource for research and development (R&D), technology deployment, education, and commercialization for the international nanotechnology industry. Under Dr. Kaloyeros’ leadership SUNY Poly has generated over $50 billion in public and private investments and has created and retained over 15,000 high-tech jobs in Upstate New York.

Dr. Kaloyeros holds a PhD in Experimental Condensed Matter Physics with honors from the University of Illinois, Urbana-Champaign. Over the course of a distinguished career in academia, he has authored or co-authored over 250 scientific articles in technical journals with rigorous peer review procedures and contributed to 8 books on topics pertaining to the science and technology of nanotechnology, nanoelectronics, nano-optoelectronics, nanomedicine and green energy. His scientific focus has been ultrathin film materials and structures, atomic layer vapor phase deposition processes, nanoscale x-ray, electron, and photon-based characterization and metrology. He has graduated more than 36 PhD’s and over 100 Master’s throughout his teaching career and his research has been referenced in over 7200 citations by peers in leading scientific and technical publications. He has been awarded 31 individual and joint U.S. and international patents and is currently pursuing an additional 15 provisional and full U.S. and international patent applications. His body of work has led so far to a Hirsch Index (h-index) score of 41 for Academic Productivity and Scholarly Achievements as documented by Google Scholar, among the most prestigious international measures of scholarly excellence.

Over his career, Dr. Kaloyeros is the distinguished recipient numerous awards and recognitions including the National Science Foundation Presidential Young Investigator Award; NSF Research Initiation Award; Albany Foundation Academic Laureate Award; Center for Economic Growth Enterprise Award; Citizen of the University Award; Outstanding Inventor Award of the SUNY Research Foundation; R&D 100 Award for one of the Most Technologically Significant Inventions of 2001; Tech Valley MIKE (Mentorship, Innovation, Knowledge, and Entrepreneurship) Award; “Tech Valley’s Hot 10,” an annual list of the “top 10 movers and shakers” in New York’s Capital Region; and Honorary Degree of Doctor of Science, Hartwick College.


Douglas R. Wulffleff

Mr. Doug Wulffleff is a highly regarded business executive with over 35 years of experience in corporate ownership transition and a record of over 100 successful global business and company transactions.

He has served in various transaction related leadership positions including at BT Securities (Bankers Trust), as a global corporate finance Partner at Arthur Anderson, LLP, Managing Director of M&A for BDO Canada, and VP of Strategy and Corporate Development at VWR International. He presently serves as Senior Vice President of Corporate Development at Catemer, Inc. and TCP Analytical, LLC as well as an Executive Advisor to New Mountain Capital where he previously served as Senior Vice President of M&A to New Mountain chemical industry portfolio companies Gelest, Inc. (working with Barry Arkles Ph.D. and Alain E. Kaloyeros, Ph.D.), Aceto (now Actylis) and Ascensus Specialties.

His deep industry knowledge spans life sciences, specialty chemical manufacturing and distribution, biopharma manufacturing, single use manufacturing and clinical trials kitting.

Mr. Wulffleff received his M.B.A. in finance with High Honors from Adelphi University and his A.B. from Colgate University.


Contact Us to learn how we can help you.